Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry

Authors: J Beyer-Westendorf, A.J Camm, S Virdone, K.A.A Fox, K.S Pieper, J.-Y Le Heuzey, S Haas, G Kayani, B.J Gersh, A.G.G Turpie, A.K Kakkar,

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.0578

Source: Full article


Abstract

Abstract